Nymox Pharmaceutical
NYMX
#10106
Rank
S$23.3 M
Marketcap
Country
S$0.26
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -S$3.04 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -S$8.34 Million, an increase over its 2021 earnings that were of -S$15.94 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -S$3.04 Million-63.57%
2022 -S$8.34 Million-47.71%
2021 -S$15.94 Million6.61%
2020 -S$14.95 Million-10.91%
2019 -S$16.78 Million24.24%
2018 -S$13.51 Million-20.03%
2017 -S$16.89 Million2.71%
2016 -S$16.44 Million-63.86%
2015 -S$45.5 Million674.44%
2014 -S$5.88 Million-6.11%
2013 -S$6.26 Million-35.66%
2012 -S$9.73 Million-20.76%
2011 -S$12.28 Million38.33%
2010 -S$8.88 Million35.59%
2009 -S$6.55 Million11.8%
2008 -S$5.86 Million-12.94%
2007 -S$6.73 Million8.85%
2006 -S$6.18 Million36.5%
2005 -S$4.53 Million-4.4%
2004 -S$4.74 Million-14.58%
2003 -S$5.55 Million
2001 -S$4.07 Million-20.54%
2000 -S$5.12 Million21.72%
1999 -S$4.21 Million-25.56%
1998 -S$5.65 Million101.3%
1997 -S$2.81 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$41.36 B-1,499,220.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$15.13 B-548,549.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$10.39 B-376,684.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$28.73 B-1,041,451.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
S$1.64 B-59,655.76%๐Ÿ‡บ๐Ÿ‡ธ USA